EUVIMEDEUVIMED entdecken
Open Access

Discontinuation Categories Underlying Gaps in Dispensing for Six Medication Groups

Elizabeth A Bayliss iD, Glenn K Goodrich, Jennifer C Barrow, Bill Harding, Courtney A Ripley, Courtney R Kraus, Valerie Paolino, Jonathan D Norton, Orla C Sheehan, Linda A Weffald, Ariel R Green, Ted E Palen und 3 weitere

Pharmacoepidemiology and Drug Safety · 2025-04 · 34 (4)

DOI: 10.1002/pds.70142 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 08.04.2025. Verfasst von Elizabeth A Bayliss und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Deprescriptions. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HSRD VA, NIA NIH HHS, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Accurately identifying medication discontinuations at scale is important for developing evidence about deprescribing. Gaps in dispensing often serve as proxies for discontinuation but are imprecise. We categorize reasons for gaps in dispensing to inform data‐based methods to accurately identify medication discontinuations.

Methods

Using pharmacy dispensing data, we purposively sampled from a population of adults age 65+ with 2+ chronic conditions who experienced a 90‐day gap in dispensing—with and without subsequent fills—of oral diabetes drugs, statins, proton pump inhibitors, drugs with anticholinergic properties, anticoagulants and antiplatelet drugs, or antihypertensives. We reviewed clinical documentation (e.g., visit notes, communications, medication orders) from last dispensing through the 90‐day gap plus 120 days to classify dispensing gaps as true discontinuations (clinically intended) or non‐discontinuations (no evidence of intent to discontinue), and then into subcategories. Medications with no documented explanation for the gap in dispensing and continued listing on the patient's medication list were classified as non‐discontinuations.

Results

Of N = 1906 records reviewed, there were 1068 (56%) true discontinuations and 838 (44%) non‐discontinuations. Subcategories within true discontinuations included provider intent to discontinue, provider substitutions, intentional stops followed by restarts, and agreeing with a colleague's or patient's decision to discontinue. Non‐discontinuations included documented low adherence, changes in dose, changes in pharmacy formulary, and changes in drug formulation. Proportions of drugs in categories and subcategories varied by medication group.

Conclusion

Using gaps in dispensing as proxy measures for medication discontinuation may introduce bias through misclassification, and varied reasons for discontinuation may complicate causal interpretations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DeprescriptionsHumansAgedFemaleMaleAged, 80 and over

Stichwörter der Autor:innen

deprescribingmedication discontinuationnatural language processingpharmacoepidemiologypragmatic trials

Autor:innen und Institutionen

  • Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado, USA.
  • Department of Family Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
  • Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Department of Medicine for the Older Person, Connolly Hospital, Dublin, Ireland.
  • Department of Clinical Pharmacy, Kaiser Permanente Colorado, Aurora, Colorado, USA.
  • Quality Use of Medicines and Pharmacy Research Centre, School of Pharmacy and Medical Science, University of South Australia, Adelaide, South Australia, Australia.

ORCID-Profile: Elizabeth A Bayliss

Förderung

  • HSRD VA
  • NIA NIH HHS
  • National Institute on Aging

Zitieren

APA

Bayliss, E. A., Goodrich, G. K., Barrow, J. C., Harding, B., Ripley, C. A., Kraus, C. R., Paolino, V., Norton, J. D., Sheehan, O. C., Weffald, L. A., Green, A. R., Palen, T. E., Reeve, E., Maciejewski, M. L., & Boyd, C. M. (2025). Discontinuation Categories Underlying Gaps in Dispensing for Six Medication Groups. Pharmacoepidemiology and Drug Safety, 34(4). https://doi.org/10.1002/pds.70142

Vancouver

Bayliss EA, Goodrich GK, Barrow JC, Harding B, Ripley CA, Kraus CR, et al. Discontinuation Categories Underlying Gaps in Dispensing for Six Medication Groups. Pharmacoepidemiology and Drug Safety. 2025;34(4). doi:10.1002/pds.70142

BibTeX
@article{Bayliss2025,
  author = {Bayliss, Elizabeth A and Goodrich, Glenn K and Barrow, Jennifer C and Harding, Bill and Ripley, Courtney A and Kraus, Courtney R and Paolino, Valerie and Norton, Jonathan D and Sheehan, Orla C and Weffald, Linda A and Green, Ariel R and Palen, Ted E and Reeve, Emily and Maciejewski, Matthew L and Boyd, Cynthia M},
  title = {Discontinuation Categories Underlying Gaps in Dispensing for Six Medication Groups},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2025},
  volume = {34},
  number = {4},
  doi = {10.1002/pds.70142}
}
Kostenlos starten →